Acute Low Back Pain (Low Back Pain for Less Than 3 Months) Clinical Trial
Official title:
Shockwave Therapy for Acute Low Back Pain: a Randomized Placebo-controlled Clinical Trial
| Verified date | January 2021 |
| Source | University Hospital Muenster |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to determine whether shockwave therapy is more effective in the treatment of unspecific acute low back pain than sham therapy. 60 patients with acute low back pain will be recruited to a single-blinded, randomized, placebo-controlled trial. They are randomized to receive either shockwave therapy or sham treatment by a identically looking device for 4 weeks, twice a week. Additionally patients receive physiotherapy twice a week and are allowed to take an anti-inflammatory drug, if necessary for even 4 weeks. The primary outcome variable will be measured at day 0, every week during treatment (day 7; 14; 21 and 28) and up to 4 weeks after the last treatment. The clinical outcome will be primarily measured by pain intensity using a visual analogue scale. Secondary outcome measures are Oswestry Disability Index, Beck's Pain Depression Scale, Roland Morris Disability Questionnaire and the EQ-5D. Data will be analysed for the difference in change of scores between groups using one-way t-test.
| Status | Completed |
| Enrollment | 63 |
| Est. completion date | January 15, 2019 |
| Est. primary completion date | September 13, 2018 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 65 Years |
| Eligibility | Inclusion Criteria: low back pain for less than 3 months Exclusion Criteria: - Patients with relevant leg pain - Patients with spine operations in the past - neurologic symptoms - scoliosis with Cobb angle > 10° - Patients experienced in shock wave therapy - Patientes with ongoing therapy with blood diluting drugs such as phenprocumon - Patients with osteoporosis - Patients with back pain after trauma - Patients with infective diseases or tumor diseases - Patients with relevant psychological diseases |
| Country | Name | City | State |
|---|---|---|---|
| Germany | Universitätsklinikum Münster, Klinik für Allgemeine Orthopädie und Tumororthopädie | Münster | NRW |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital Muenster |
Germany,
Barker KL, Elliott CJ, Sackley CM, Fairbank JC. Treatment of chronic back pain by sensory discrimination training. A Phase I RCT of a novel device (FairMed) vs. TENS. BMC Musculoskelet Disord. 2008 Jun 28;9:97. doi: 10.1186/1471-2474-9-97. — View Citation
Seco J, Kovacs FM, Urrutia G. The efficacy, safety, effectiveness, and cost-effectiveness of ultrasound and shock wave therapies for low back pain: a systematic review. Spine J. 2011 Oct;11(10):966-77. doi: 10.1016/j.spinee.2011.02.002. Epub 2011 Apr 9. Review. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in pain, using visual analogue scale (VAS) | Change in pain, using visual analogue scale (VAS 1-10) | Day 0; 7; 14; 21; 28, after 6 and 8 weeks. | |
| Secondary | Change in other clinical questionnaires (Oswestry disability Index) | Oswestry disability Index | day 0; 7; 14; 21, after 6 and 8 weeks. | |
| Secondary | Change in other clinical questionnaires (Beck's depression scale) | Beck's depression scale | day 0; 7; 14; 21, after 6 and 8 weeks. | |
| Secondary | Change in other clinical questionnaires (EQ-5D) | EQ-5D | day 0; 7; 14; 21, after 6 and 8 weeks. | |
| Secondary | Change in other clinical questionnaires (Roland-Morris-Score) | Roland-Morris-Score | day 0; 7; 14; 21, after 6 and 8 weeks. |